| Autor: |
Ames FQ; Department of Pharmacology and Therapeutics, State University of Maringá, Avenida Colombo, 5790, Maringá, Paraná, Brazil., Bracht L; Department of Biochemistry, State University of Maringá, Maringá, Paraná, Brazil., Schneider LCL; Department of Morphological Sciences, State University of Maringá, Maringá, Paraná, Brazil., Rocha BA; Department of Pharmacology and Therapeutics, State University of Maringá, Avenida Colombo, 5790, Maringá, Paraná, Brazil., Santos GA; Department of Pharmacology and Therapeutics, State University of Maringá, Avenida Colombo, 5790, Maringá, Paraná, Brazil., Lima EP; Department of Pharmacology and Therapeutics, State University of Maringá, Avenida Colombo, 5790, Maringá, Paraná, Brazil.; Department of Biochemistry, State University of Maringá, Maringá, Paraná, Brazil., Rocha EMT; Department of Pharmacology and Therapeutics, State University of Maringá, Avenida Colombo, 5790, Maringá, Paraná, Brazil., Cuman RKN; Department of Pharmacology and Therapeutics, State University of Maringá, Avenida Colombo, 5790, Maringá, Paraná, Brazil., Bersani-Amado CA; Department of Pharmacology and Therapeutics, State University of Maringá, Avenida Colombo, 5790, Maringá, Paraná, Brazil. cabamado@uem.br. |
| Abstrakt: |
Anethole (AN) is a natural compound that has attracted great scientific interest because of its numerous biological activities, including anti-inflammatory effects. However, these effects were obtained with high doses of AN, which may be one limitation of its therapeutic use. This study evaluated the effects of a low-dose AN and ibuprofen (IB) combination on inflammatory parameters in Freund's complete adjuvant-induced arthritis (AIA) and arthritis-induced hepatic metabolic changes. Holtzman rats were used and divided into groups: normal, AIA (control), arthritics treated with IB, arthritics treated with AN, and arthritics treated with AN + IB. The volume of the paws, the appearance of secondary lesions, and the number of synovial leukocytes were evaluated. Gluconeogenesis and ureagenesis from alanine were determined in the rat liver in isolated perfusion. The AN + IB (62.5 + 8.75 mg/kg) treatment exerted an inhibitory effect on inflammatory parameters and partially prevented hepatic metabolic changes that was similar to the effect of high-dose IB (35 mg/kg) and AN (250 mg/kg) treatment. This effect of the treatments on hepatic metabolism can be, partly at least, explained by the preservation of both the alanine aminotransferase (ALT) activity and the cytosolic NADH/NAD + redox potential in the liver. Taken together, the data obtained provided evidence that the AN + IB combination at lower doses than AN and IB treatment alone had beneficial inhibitory potential for the treatment of AIA and attenuated metabolic changes in the liver. Graphical Abstract. |
Full text from SpringerLink